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Human and Microbial Proteins 
From Corpora Amylacea of 
Alzheimer’s Disease
Diana Pisa1, Ruth Alonso1, Ana Isabel Marina1, Alberto Rábano2 & Luis Carrasco1
Corpora amylacea (CA) are spherical bodies mainly composed of polyglucans and, to a lesser extent, 
proteins. They are abundant in brains from patients with neurodegenerative diseases, particularly 
Alzheimer’s disease. Although CA were discovered many years ago, their precise origin and function 
remain obscure. CA from the insular cortex of two Alzheimer’s patients were purified and the protein 
composition was assessed by proteomic analysis. A number of microbial proteins were identified and 
fungal DNA was detected by nested PCR.A wide variety of human proteins form part of CA. In addition, 
we unequivocally demonstrated several fungal and bacterial proteins in purified CA. In addition to a 
variety of human proteins, CA also contain fungal and bacterial polypeptides.In conclusion, this paper 
suggests that the function of CA is to scavenge cellular debris provoked by microbial infections.
Several different types of polyglucan bodies have been found in the central nervous system (CNS) of elderly peo-
ple, as well as in patients with a variety of pathologies, including Alzheimer’s disease (AD), epilepsy, amyotrophic 
lateral sclerosis (ALS), multiple sclerosis (MS) and hippocampal sclerosis1,2. Among these polyglucan structures, 
Lafora bodies, Bielschowsky bodies and corpora amylacea (CA) have been identified based on their morphological 
characteristics3–5. Although CA were described early in the 18th century, their precise origin and potential function 
in normal or pathological conditions remains an enigma. The presence of CA in brain tissue was first described by 
Purkinje in 1837, and the Cajal school analyzed these structures, suggesting that they are formed by the microglia.
CA are amorphous rounded bodies approximately 10−50 μm in diameter. These glycoproteinaceous lami-
nar structures accumulate in the brain during the course of normal aging and to a greater extent in the CNS of 
AD patients6–8. Of note, abundant CA are also found in some patients diagnosed with temporal epilepsy, where 
extensive deposits of CA have been observed in brain tissue9,10. Interestingly, CA have a perivascular distribution 
and are much more abundant in close proximity to blood vessels10–12. In addition to the CNS, CA are found in 
other organs and tissues, such as normal prostate, muscle, liver, lung, prostate tumours and other malignant tis-
sues13–18. CA mostly contain polyglucans (over 85% are hexoses), with a minor component (4%) of proteins19. The 
rounded core is formed by different calcium salts, principally calcium phosphate and calcium oxalate depending 
on the bodies analyzed20–22. In general, a broad range of proteins can be found in CA and a number of them 
have been characterized using specific antibodies23. Accordingly, several blood proteins such as thrombospon-
din 1, some complement components, ubiquitin, heat-shock proteins and tau protein processed by caspase-3 
have been detected in CA24–28. The protein composition of CA from prostate has been characterized in detail by 
proteomic analysis, showing that lactoferrin is the most abundant protein, together with myeloperoxidase, S100 
calcium-binding proteins A8 and A9, which form the inflammatory protein calprotectin, and α-defensins, which 
form part of neutrophil granules29. Curiously, calprotectin is also present in CA from normal human brains30. 
The suggestion that CA are built up from breakdown products from neurons and oligodendroglial cells has been 
proposed23. Along this line, proteomic analysis of brain CA from patients with MS revealed the presence of 
cytoskeleton proteins and enzymes of the anaerobic glycolysis pathway . A number of microorganisms have also 
been suggested as the source of the chronic inflammation that triggers the formation of CA in prostate. Among 
these, several bacteria such as Chlamydia trachomatis, Escherichia coli and Pseudomonas spp., protozoa such as 
Trichomonas vaginalis and viruses known to contribute to different types of cancer, including human papillo-
mavirus, have been considered29,31. Thus, the concept that CA represent the prostate response to a microbial 
infection has been proposed.
1Centro de Biología Molecular “Severo Ochoa” (CSIC-UAM). c/Nicolás Cabrera, 1. Universidad Autónoma de Madrid. 
Cantoblanco., 28049, Madrid, Spain. 2Department of Neuropathology and Tissue Bank, Unidad de Investigación 
Proyecto Alzheimer, Fundación CIEN, Instituto de Salud Carlos III, Madrid, Spain. Correspondence and requests for 
materials should be addressed to L.C. (email: lcarrasco@cbm.csic.es)
Received: 24 November 2017
Accepted: 14 June 2018
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2Scientific REPORTS |  (2018) 8:9880  | DOI:10.1038/s41598-018-28231-1
We have recently reported that CA from brain tissue of AD, ALS and patients with Parkinson’s disease contain 
fungal components, as revealed by immunoreactivity against antifungal antibodies32. However, the exact proteins 
present in CA were not identified. We have proposed that CA represent a response to the microbial infection 
present in these patients. Thus, this proposal reconciles the idea that CA are built up by cellular breakdown 
products, which originate from the microbial infection that exists in the CNS from patients with these neurode-
generative diseases. Indeed, there is strong evidence for the presence of fungal proteins and DNA in CNS from 
AD patients33–35, and also in patients diagnosed with ALS36,37. In the current study, we have characterized in detail 
the fungal and bacterial proteins that can be found in purified CA from two AD patients. In addition, the human 
proteins present in CA reveal a great variety of cellular polypeptides, consistent with the concept that CA repre-
sent breakdown products of neural cells.
Results
Purification of CA from brain tissue. Our initial goal was to develop a protocol to purify CA from brain 
tissue. We analyzed tissue from two patients (AD1 and AD2) diagnosed with AD; patient AD2 was also diagnosed 
with dementia with Lewy bodies. Prior results from our group have demonstrated the existence of fungal proteins 
in CA from brain sections of AD patients32. Accordingly, the presence of CA was first examined by periodic acid-
Schiff (PAS) staining and by immunohistochemistry using antibodies against human α-tubulin, C. albicans and 
also bacterial peptidoglycan. Abundant CA were observed in insular cortex (INCO) tissue sections in patient 
AD1 by PAS staining and by immunohistochemistry (Fig. 1). For this reason, brain tissue from this INCO region 
was selected. Interestingly, CA immunoreacted with both antifungal and antibacterial antibodies, suggesting the 
presence of microbial components in CA. Similar results were found in patient AD2, although CA were less abun-
dant in the sections examined from this patient (Supplementary Fig. 1A).
To obtain purified CA, we used the protocol described in Materials and Methods. Homogenized tissue was 
pelleted through a series of centrifugation steps on sucrose cushions to obtain a final pellet named P7. The pro-
teins of the first homogenate and the P7 fraction were analyzed by SDS-PAGE under reducing conditions and 
visualized by Coomassie blue staining. Analysis showed evident differences in protein content between the first 
homogenate and the P7 pellet (Supplementary Fig. 1B). In addition, the P7 pellet was immunostained with an 
anti-C. albicans antibody to visualize the purified CA in this fraction. Notably, CA was evidenced in P7 from both 
patients after immunostaining with the fungal antibody (Supplementary Fig. 1C). These findings clearly indicate 
that P7 contains CA bodies, but we cannot rule out the possibility that other human proteins present in organelles 
also form part of this fraction. It is unlikely that soluble cellular proteins obtained during the homogenization 
procedure remain in P7, since the components of this fraction were sedimented through 25–45% sucrose and 
this step was repeated several times. However, it should be possible that soluble cellular proteins interact with CA 
during their formation. To test this possibility directly, we subjected fractions H and P7 to western blotting using 
an antibody against the translation initiation factor eIF4GI. This factor was clearly detected in fraction H, but 
not in P7 (Supplementary Fig. 2A, see also Supplementary info file). Furthermore, whereas the translation elon-
gation factor eEF2 was detected only sparingly in fraction H, CA clearly accumulated this protein. Also, human 
α-tubulin was found both in fractions H and P7. Interestingly, 18S rRNA was detected by RT-PCR in the P7 frac-
tion from both patients. By contrast, mtDNA was only found in the H and P2 fractions, but not in P7, reflecting 
that mitochondria do not co-purify with CA and that these organelles are not recruited by CA (Supplementary 
Fig. 2B, see also Supplementary info file).
As regards to CA from control subjects, their amount was very low (Supplementary Fig. 3). Only some CA can 
be revealed in the entorhinal cortex/hippocampus (ERH) using antibodies against human α-tubulin. Therefore, 
purification of these bodies by our present protocol was precluded. The best characterization of CA from control 
subjects can be accomplished by immunohistochemistry. However, immunolabeling with anti-C. albicans anti-
bodies was not found (Supplementary Fig. 3). Besides, no signal was observed with anti-peptidoglycan antibod-
ies. These findings are in good agreement with previous results38.
Human proteins detected in purified CA. After determining that P7 contains CA, we next sought 
to characterize this fraction using proteomic analysis. Initially, we sought to identify the human proteins 
that constitute CA. To do this, CA samples were digested with trypsin and analyzed by MS. Supplementary 
Table I and Table II list the human proteins that are found in P2 and P7 fractions from both patient AD1 and 
AD2, with at least two peptides. The human proteins detected were classified according to their function 
(Fig. 2). Most of these peptides belong to nucleic acid binding proteins, cytoskeleton and enzymatic pro-
teins. Interestingly, a number of these proteins were detected in P2, but not in P7 and vice versa, while others 
were common to both fractions (Supplementary Tables III and IV). The major finding of this proteomic 
analysis was the great variety of human proteins detected in P7, presumably forming part of CA. Evidently, 
some of these proteins could be minor components of CA and/or could be present in a small fraction of 
these bodies due to their heterogeneity.
Fungal proteins in CA. As stated above, fungal infection can be evidenced in AD brains by immunohisto-
chemistry34,39, which is consistent with the detection of fungal proteins in CA from AD1 and AD2 (Fig. 1 and 
Supplementary Figure 1). We therefore investigated the presence of mycotic structures in the different fractions 
of CA. We found that the P2 fraction from both patients contained a significant proportion of yeast-like and 
hyphal structures that could be detected by immunostaining with a specific anti-C. albicans antibody (Fig. 3A). 
We also analyzed the fractions by western blotting using different antifungal antibodies. Figure 3B (see also 
Supplementary info file) shows a number of different protein bands that immunoreacted with the anti-Phoma 
betae and anti- C. albicans antibodies. To identify the fungal species present in the two patients, we performed 
nested PCR of the fungal ITS-1 and ITS-2 regions (Fig. 3C, see also Supplementary info file). Fungal DNA 
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fragments were successfully amplified in fractions H and P7, which after sequencing, revealed a variety of fungal 
species present in both patients (Supplementary Table V). The fungal genera identified included Cladosporium, 
Malassezia or Rhodotorula. These fungal genera correspond with those previously described by our group34,40.
Figure 1. Histochemistry analysis of brain sections from patient AD1. Evidence of CA in the brain cortex 
containing microbial proteins. Insula cortex (INCO) sections from patient AD1 stained with Periodic acid–
Schiff reagent (upper panel); immunostained with a rabbit polyclonal anti-C. albicans antibody (green) used 
at 1:100 dilution, and a mouse monoclonal anti-human α-tubulin antibody (red) used at 1:50 dilution (middle 
panel); immunostained with a mouse monoclonal anti-peptidoglycan antibody (green) used at 1:20 dilution, 
and a rabbit polyclonal anti-C. albicans antibody (red) used at 1:100 dilution (lower panel). DAPI staining of 
nuclei appears in blue. Scale bar: 50 μm.
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The presence of fungal proteins in CA as revealed by immunohistochemistry using different antibodies does 
not identify the precise proteins in these bodies32 (Fig. 1). Thus, to demonstrate that fungal proteins form part of 
CA and to identify them with precision, the peptides obtained after tryptic digestion of P2 and P7 were analyzed 
Figure 2. Proteomic analysis of P2 and P7 fractions from patients AD1 and AD2. Identification of the 
human proteins present in these fractions. Analysis of the human proteins in CA (fraction P7) by proteomics. 
Classification of the proteins found in P2 and P7 according to protein class function was carried out using 
Panther online software. Upper panels: P2 and P7 from AD1, and P2 and P7 from AD2. Lower panels: 
comparison of the proteins that appear in P2 and P7 from AD1 and AD2. Red: proteins absent in P7 and present 
in P2. Green: proteins present in P7 and absent in P2. Blue: proteins common to both P2 and P7.
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against the fungi database using the Proteome Discoverer 1.4 tool. Obviously, the vast majority of peptides 
obtained after tryptic digestion were of human origin and we only considered bona fide peptides belonging to 
fungi. Through this analysis, several fungal peptides from P2 and P7 could be unambiguously ascribed in the 
most part to cytoskeleton proteins (Table 1). It seems logical that the most abundant proteins in fungal cells, i.e., 
cytoskeletal proteins, appear in CA.
Bacterial proteins detected in purified CA. To complement our studies on human and fungal proteins 
in CA, we extended our analysis to the possibility that viral or bacterial proteins are also present in these samples. 
Indeed, we and others have recently reported that a variety of bacterial species are detected in brain tissue from 
AD patients39,41. Moreover, prokaryotic-like cells immunopositive for peptidoglycan could be detected in INCO 
tissue sections (Fig. 1). To test the existence of bacterial proteins, the peptides obtained in P7 from both AD1 
Figure 3. Fungal proteins and DNA in the homogenate and P7 fractions from patients AD1 and AD2. 
Identification of fungal components in CA. (A) Pellet (P2) of AD2 immunostained with a rabbit polyclonal 
anti-C. albicans antibody (green) used at 1:100 dilution. DAPI staining of nuclei appears in blue. Scale bar: 
10 μm. (B) Western blot of proteins from homogenate (H) and P7 fractions from AD1 and AD2. Left panel: 
Rabbit polyclonal anti-P. betae antibody used at 1:500 dilution; right panel: rabbit polyclonal anti-C. albicans 
antibody used at 1:100 dilution. (C) Nested PCR analysis of DNA extracted from patients AD1 and AD2. 
Agarose gel electrophoresis of the DNA fragments amplified by nested PCR. Left panel: PCR analysis of the 
homogenate (H) and P7 fractions from patients AD1 and AD2 using primers ITS-5 and ITS-3 to amplify the 
ITS-1 region. Right panel: PCR analysis of the H and P7 fractions from patients AD1 and AD2 using primers 
ITS-3 and ITS-4 to amplify the ITS-2 region. (C) Control of PCR without DNA. CE: Control of DNA extraction 
without DNA. H: Homogenate. P7: fraction 7. See also Supplementary info file.
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and AD2 patients were tested against bacterial databases belonging to different phyla. Only those peptides that 
unequivocally belong to bacteria were considered. Interestingly, the high sensitivity of the proteomic analyses 
identified a few peptides that could be ascribed to bacteria. The bacterial peptides, the corresponding proteins and 
the phyla are listed in Table 2. Only three prokaryotic peptides were found in AD1 and one in AD2. Of note, the 
number of bacterial peptides detected was lower than those of fungal origin, possibly reflecting the lower burden 
of bacterial infection as compared with mycotic infection. Finally, the peptides obtained after tryptic digestion 
of P2 and P7 were also analyzed against the database of DNA animal viruses to identify potential proteins from 
these viruses. No peptides corresponding to herpesviruses or any other DNA virus were found in P2 or P7 from 
both AD patients, which is consistent with our recent report that HSV-1 proteins are not detected in brain tissue 
from AD patients39.
In-depth analysis of fungal proteins. Our finding that fungal proteins are present in a lower proportion 
than human proteins prompted us to analyze in more detail these proteins in the P7 fraction from both patients. 
To do this, proteins were fractionated by a high-pH, reversed-phase fractionation spin column. Nine fractions 
were obtained and were subsequently pooled into three fractions F1, F2 and F3, as described in Materials and 
Methods. After MS analyses of F1, F2 and F3, the number of fungal peptides detected increased considerably 
(Table 3). Thus, the number of peptides unambiguously identified as fungal were 49 in P7 from AD1 and 70 in 
P7 from AD2, from those 23 were common to both patients. These peptides corresponded to a number of fungal 
proteins mostly belonging to tubulins and actins, in agreement with the fact that these proteins are very abundant. 
These findings reinforce our previous observations that fungal infection exists in AD patients.
PEPTIDE PROTEIN SPECIES AD1-P2 AD1-P7 AD2-P2 AD2-P7
GHYTEGAELIDSVLDVVR Beta tubulin Several species — YES YES YES
GHYTEGAELVEAVLDVVR Beta tubulin Several species YES — — —
MAATFIGNSTAQQELFK Beta tubulin Several species — YES — YES
MSATFIGNSTSIQELFK Beta tubulin Several species — — YES —
MSVTFIGNSTAIQELFK Beta tubulin Several species — — YES YES
MSVTFLGNSTAIQELFK Beta tubulin Several species — YES — —
MSVTLIGNSTAIQELFK Beta tubulin Rhizophlyctis rosea YES — — —
NSSYYVEWIPNNVK Beta tubulin Blastocladiella emersonii — YES — —
SLGGGTGAGMGTLLISK Beta tubulin Several species YES — — —
AICMLSNTTAIAEAWAR Alpha tubulin Lichtheimia sp — — YES —
ALCMLSNTTAIAEAWAR Alpha tubulin Several species YES YES — YES
AVCMLSNTTAIAEAWSR Alpha tubulin Several species — — — YES
AVCMLSNTTAISEAWSR Alpha tubulin Geotrichum candidum — YES — YES
IHFPLATYAPIISAEK Alpha tubulin Several species — YES YES —
IHFPLATYAPLISADK Alpha tubulin Several species — YES — —
IHFPLATYAPLLSAEK Alpha tubulin Several species YES — — YES
LIAQVVSSITASLR Alpha tubulin Several species YES — YES —
DSYVGDEAESK Actin Fusarium oxysporum — — YES —
GEEEVAALVIDNGSGMCK Actin Cryptococcus depauperatus YES YES YES YES
SYELPDGQNITIGNER Actin Nematocida sp YES YES YES —
TYELPDGQVITIGNER Actin Several species — — — YES
LILEVAQHLGESTVR ATP synthase subunit beta Ophiostoma piceae YES — YES —
VALTGLTIAEYFR ATP synthase subunit beta Several species YES — YES —
VSLVFGQMNEPPGAR ATP synthase subunit beta Several species YES — — —
IEIIANDQGNR Heat shock protein Several species YES — YES —
SLTNDWEEHLAVK Heat shock protein Several species YES — — —
FFTPEEISSMVLTK Unplaced genomic scaffold Several species — — YES —
Table 1. Fungal peptides in P2 and P7 fractions from AD1 and AD2.
PEPTIDE PROTEIN AD1-P7 AD2-P7 PHYLUM
LINEPTAAALAYGLSR Chaperone protein DnaK YES — proteobacteria
LLNEPTAAALAYGVEK Chaperone protein HscA — YES proteobacteria
FTQAGSEISALLGR ATP synthase subunit beta YES — proteobacteria tenericutes
NETDDQVTIDAAEATKK Isocitrate dehydrogenase [NADP] YES — firmicutes
Table 2. Bacterial peptides in P2 and P7 fractions from AD1 and AD2.
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Discussion
Knowledge on the precise protein composition of CA from the CNS may shed light on the origin of these bodies. 
In this regard, our current findings provide evidence for the complexity of the proteins that form part of CA, 
consistent with the notion that these proteins could be debris of dead cells, or could appear in the intercellular 
space, or are extravasated polypeptides12,25. Our results show that P7 contains CA and they are likely devoid of 
contamination by soluble cellular proteins and mitochondria. The finding of ribosomal components in P7 sug-
gests that ribosomes are recruited to CA when they formed. Alternatively, it should be possible that ribosomes 
cosediment with CA, although this possibility is unlikely due to the purification protocol employed. However, not 
all cellular proteins are represented in the same proportion in CA and in the CNS tissue since some of them, such 
as eIF4GI, appeared in the tissue homogenate but not in CA. Comparison of proteins from P2 and P7 fractions 
indicated that whereas some of them are common to both fractions, each fraction contains several unique protein 
species. Perhaps the stability of the proteins, or their propensity to interact with polyglucans or with other pro-
teins, dictate their fate to form part of CA. Aside from this complexity, another important concept in CA is their 
heterogeneity. For example, immunohistochemistry analyses revealed that not all CA stained equally with a given 
antibody. Some of them contained a given human protein while others in the same preparation contained less 
or were devoid of that protein. Heterogeneity can also exist between CA from different brain regions, and more 
important, between those found in AD and in elderly subjects. This heterogeneity also raises questions about the 
concept that CA simply agglutinate proteins in a random fashion. If so, CA could be envisaged as scavengers of 
cellular debris products that would be generated after cell injury. In agreement with this idea, myelin injury in 
patients with AD leads to the degradation of myelin basic protein, which appears in CA42.
Our proposal that CA contain fungal proteins based on the observation that they immunoreact with anti-
fungal antibodies32 is now substantiated by proteomic analysis. Moreover, we can conclude that both fungal 
and bacterial proteins can be found in purified fractions of CA from AD patients. We recently reported that 
prokaryotic-like cells and bacterial DNA can be detected in brain tissue from AD39, expanding our previous 
results of fungal infection of the CNS in these patients32,33. Consistent with our findings, bacterial DNA has also 
been recently detected by next generation sequencing in Alzheimer’s brains41. Moreover, in support of the idea 
that polymicrobial infections are present in AD CNS is the observation that the amyloid peptide exhibits antifun-
gal and antibacterial activity43. In this regard, the production of amyloid has been considered as part of the innate 
immune system and is synthesized in brain tissue as a response to microbial infections44. We believe that these 
findings are important to understand the origin of CA and their potential function. Accordingly, we posited that 
CA originate from fungal infection32. We now extend this hypothesis to consider both fungal and bacterial infec-
tions as the trigger for CA formation. In this regard, CA may represent a response to agglutinate cellular debris 
provoked by cell damage that in turn is the result of microbial infection. In addition, fungal and bacterial proteins 
will also be agglutinated through the adhesive properties of polyglucans. The local decrease in pH as a result of 
these infections will also induce the precipitation of calcium salts, which will also be trapped in CA. According 
to our hypothesis CA in AD patients originate because there is a microbial infection in the CNS, and their func-
tion would be to remove breakdown components from human and microbial cells. However, other possibilities 
to explain the origin of CA could be envisaged. For instance, the modification of the blood-brain barrier by the 
previous formation of CA could facilitate microbial colonization of the CNS. Then, glial activation could proceed, 
leading to microbial destruction and the consequent accumulation of fungal proteins in CA.
The existence of CA in other tissues of the human body as well as in the CNS of elderly people without neuro-
degenerative diseases could also be a consequence of microbial cells that may exist in much lower amounts than 
those found in AD patients. Indeed, bacteria have been detected in the CNS of control human subjects39,41,45. 
These microbial cells may have a tendency to locate in close proximity to blood vessels, where oxygen and nutri-
ents are more abundant. This is in accord with the finding that CA are distributed in perivascular areas10–12. 
Remarkably, bacterial cells have also been found in human atherosclerosis and in aortic aneurysms46–48. In addi-
tion, bacteria can also be detected in internal tissues, that otherwise should be “sterile”49. The possibility that 
fungi coexist with these bacteria in some human organs or tissues remains to be explored. Therefore, the presence 
of CA in other tissues may be a consequence of low burdens of microbial cells that, with time, may increase in 
number and provoke clinical symptoms. Indeed, in the case of CA from prostate, the suggestion that they are a 
consequence of bacterial or viral infections has been proposed31,50.
Materials and Methods
Description of subjects. The study comprised two women: one aged 92, diagnosed with AD (hereaf-
ter described as AD1), and the other aged 76, diagnosed with AD and dementia with Lewy bodies (hereafter 
described as AD2). The two cases were diagnosed according to current neuropathological consensus guide-
lines51. Samples were supplied by Banco de Tejidos, Fundación CIEN (Centro de Investigación de Enfermedades 
Neurológicas, Madrid. Spain).Brain samples from two control subjects were also tested. These two controls did 
not suffer any neurodegenerative disease. Control 1 was a woman aged 48, while Control 2 was a man aged 78. 
The brain donors were anonymous to the investigators who participated in the study. All ethico-legal documents 
of the brain bank, including written informed consent, were approved by an ethics committee external to the 
bank. The study was approved by the ethics committee of Universidad Autónoma de Madrid. The transfer of 
samples was carried out according to national regulations concerning research on human biological samples. In 
addition to the informed consents, all experiments were performed in accordance with relevant guidelines and 
regulations.
Frozen brain samples and paraffin-fixed sections from insular cortex (INCO) were used for DNA purification 
and immunohistochemistry analyses, respectively. Brain and sample processing were carried out as described pre-
viously in detail32. Briefly, rapid neuropathological autopsy was performed upon call by the donor’s proxies (mean 
post-mortem interval, 4.5 h). Immediately after brain extraction, two symmetrical brain halves were obtained in 
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MSGTFIGDSTAIQELFK Beta tubulin Absidia spinosa — — YES F1
MSGTFIGNSTAIQELFK Beta tubulin Absidia spinosa — — YES F1
AILVDLEVATMDAVR Beta tubulin Agaricus bisporus var. Burnettii — — YES F3
AVLVDLEPGTMDTTR Beta tubulin Basidiobolus microsporus YES F1 YES F3-F3
MAVTFVGNSTAIQELFK Beta tubulin Basidiobolus microsporus YES F1 — —
NSSYYVEWIPNNVK Beta tubulin Blastocladiella emersonii YES F3 — —
LGICDEPPTVVPGGDLAK Alpha tubulin Calocera sp. YES F1 — —
EVEDQMLSVQTK Beta tubulin Claviceps purpurea YES F3 — —
IAEQFTAMFR Beta tubulin Conidiobolus coronatus YES F1 — —
MCSTFIGNSTAIQELFK Beta tubulin Conidiobolus coronatus YES F1 YES F3
CVSMLSNTTAIAEAWAR Alpha tubulin Dactylellina haptotyla YES F1 YES F1-F2
LEAEAAAAAAAAAK Uncharacterized protein Daedalea quercina — — YES F1
EVEEQMLAVQTK Beta tubulin Dentiscutata heterogama YES F1 YES F3
MSATFIGNTTSIQEPFK Beta tubulin Geranomyces variabilis — — YES F2
YLVVNADEGEPQTCK NADH dehydrogenase Gonapodya prolifera YES F2 YES F3
AICMLSNTTAIAEAWAR Alpha tubulin Lichtheimia sp YES F3 YES F3
SLFHPEQLITGK Alpha tubulin Lichtheimia sp. YES F3 — —
AVLVDLEPGTMDNVR Beta tubulin Microsporidia sp. YES F3 — —
AVSIPELTQQMFDAK Beta tubulin Mycena chlorophos — — YES F3
ISVYYNEAGASK Beta tubulin Mycena chlorophos YES F2 — —
EVDVQMLNVQNK Beta tubulin Nowakowskiella elegans YES F1 — —
ALTVPELAQQMFDAK Beta tubulin Nowakowskiella hemisphaerospora YES F1 YES F1
LILEVAQHLGESTVR ATP synthase subunit beta Ophiostoma piceae — — YES F2
KSIQFVDWCPTGFK Alpha tubulin Parasitella parasitica — — YES F1
IESLEEEIRK Uncharacterized protein Parasitella parasitica — — YES F1
EIAESFLGK Heat shock protein 70 Penicillium sp. — — YES F3
EVDEQMLNVHNK Beta tubulin Phlyctochytrium californicum — — YES F2
AVCMLGNTTAIAEAWAR Alpha tubulin Phycomyces blakesleeanus YES F1 — —
LVVIGDSGVGK Uncharacterized protein Piloderma croceum YES F2 — —
MDQGFSTFFSETGAGK Alpha tubulin Pisolithus tinctorius — — YES F3
GDDGFSTFFSETGAGK Alpha tubulin Puccinia YES F1 YES F1-F2
AILIDLEPGTMDSVR Beta tubulin Puccinia sorghi — — YES F3
ALCMLSNTTAIAEAWSR Alpha tubulin Rhizopus delemar — — YES F2
EVDEQMLQVQNK Beta tubulin Rhopalomyces elegans — — YES F2
VGEAMEEGEFSEAR Alpha tubulin Schizophyllum commune YES F1 — —
HQGVMVGMSNK Actin Schizopora paradoxa — — YES F2
SMNLTRGINLLSIAEK 19 S proteasome regulatory Schizosaccharomyces octosporus — — YES F2
AILVDLEPGTMDAVR Beta tubulin Several species — — YES F1
AVLIDLEPGTMDSVR Beta tubulin Several species — — YES F3
AVLVDLEPGTMDAIK Beta tubulin Several species — — YES F1
AVLVDLEPGTMDAVR Beta tubulin Several species YES F3 YES F1
GGGTGAGMGTLLISK Beta tubulin Several species YES F3 — —
GHYTEGAELIDSVLDVVR Beta tubulin Several species — — YES F1
GTGAGMGTLLISK Beta tubulin Several species YES F1 YES F3
INVYYNEASGGKYVPR Beta tubulin Several species YES F1 — —
ISVYYNEASGGKYVPR Beta tubulin Several species — — YES F1
LAVNTVPFPR Beta tubulin Several species YES F1 — —
LGVNMVPFPR Beta tubulin Several species — — YES F1
MAATFIGNSTAQQELFK Beta tubulin Several species YES F2 YES F2
MSVTFIGNSTAIQELFK Beta tubulin Several species YES F1-F1 YES F2
MSVTFLGNSTAIQELFK Beta tubulin Several species YES F1 — —
NSAYFVEWIPNNVK Beta tubulin Several species — — YES F1
SGPFGKLFRPDNFVFGQ Beta tubulin Several species — — YES F2
TAICDIPPR Beta tubulin Several species — — YES F3
TGAGMGTLLISK Beta tubulin Several species YES F3 — —
VLVDLEPGTMDAVR Beta tubulin Several species — — YES F1
Continued
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fresh through a mid-sagital cut. The right half was frozen in −50 °C isopentane after serial cutting of the brain 
hemisphere, the cerebellar hemisphere and the brainstem. The left half was fixed in 4% phosphate-buffered for-
maldehyde during 3 weeks, and thereafter it was cut and sampled. A total 25 tissue blocks were obtained and 
embedded in paraffin. Samples from the frozen tissue were obtained with sterile instruments in a laminar flow 
hood, taking all measures to avoid contamination.
CA purification. INCO tissue (350 mg) was suspended in 1 ml phosphate buffered saline with calcium 
(PBS-Ca). The tissue was homogenized gently using a Miccra D-1 homogenizer (Miccra, Müllheim; Germany). 
A 30 μl aliquot of this homogenate was removed for later analysis. The remaining of the homogenate was cen-
trifuged through a series of sucrose solutions at 20,000 × g. Accordingly, the pellet from the first centrifugation 
step (5 min) was resuspended in 300 μl PBS-Ca (P1) and loaded onto 1.5 ml of 25% sucrose in PBS-Ca. After 
centrifugation (10 min), the pellet was again resuspended in 300 μl PBS-Ca (P2). This pellet (P2) was treated 
with 1% sodium deoxycholate and the resulting suspension was loaded onto 1.5 ml 25% sucrose in PBS-Ca and 
centrifuged as before. This pellet was resuspended in 300 μl PBS-Ca (P3) and treated with 1,000 IU RNAse T1 
(Thermoscientific, MA, USA) and 15 IU DNAse 1 (TAKARA Clontech, CA, USA) at 37 °C for 5 min. The result-
ing suspension was loaded onto 1.5 ml 25% sucrose in PBS-Ca and centrifuged as before. The pellet was again 





VNDQFTAMFR Beta tubulin Several species — — YES F2
ALCMLSNTTAIAEAWAR Alpha tubulin Several species — — YES F2
AVCALSNTTAIAEAWSR Alpha tubulin Several species — — YES F2
AVCMLSNTTAIAEAWKR Alpha tubulin Several species — — YES F1
AVCMLSNTTAIAEAWNR Alpha tubulin Several species — — YES F1
AVCMLSNTTAIAEAWSR Alpha tubulin Several species — — YES F2
AVCMLSNTTAISEAWAR Alpha tubulin Several species YES F1 YES F2
CVSMLSNTTAIAEAWSR Alpha tubulin Several species — — YES F2
DVHASVATLK Alpha tubulin Several species YES F1 — —
IIAQVVSSITASLR Alpha tubulin Several species — — YES F2
LIAQIVSSITASLR Alpha tubulin Several species — — YES F2
RTVQFVDWCPTGFK Alpha tubulin Several species YES F3 YES F2
SLCMLSNTTAIATAWSR Alpha tubulin Several species YES F1 YES F1
SVTMLSNTTAIAEAWSR Alpha tubulin Several species — — YES F2
TIQFVEWCPTGFK Alpha tubulin Several species YES F1 YES F1
TVQFVDWCPTGFK Alpha tubulin Several species YES F1 — —
TVQMVDWCPTGFK Alpha tubulin Several species — — YES F3
VGEGMEEGEFTEAR Alpha tubulin Several species YES F2 YES F2
DLTDYLMR Actin Several species — — YES F3
EEEVAALVIDNGSGMCK Actin Several species YES F3 — —
EEEVAALVVDNGSGMCK Actin Several species YES F2 — —
NYELPDGQVITIGNER Actin Several species YES F3 YES F1
VAPEEHPVLLTEAPLNPR Actin Several species YES F1 — —
IEIIANDQGNR Heat shock protein Several species — — YES F1
AMSIMNSFVNDIFER Histone H2B Several species — — YES F3
HAVSEGTRAVTK Histone H2B Several species YES F2 — —
QDLPNAMQAAEITDK ADP-ribosylation factor Several species YES F1 YES F1
SVCTEAGMYAIR 26 s protease regulatory Several species — — YES F2
TFTTQETITNAESAR Glucose-6-phosphate isomerase Several species YES F1 — —
DAGTISGLNVLR Several proteins Several species — — YES F1
IVLIGDSGVGK Several proteins Several species — — YES F2
IVNEPTAAAIAYGLDK Several proteins Several species YES F2 YES F2
VIVLGDSGVGK Several proteins Several species — — YES F2
DVNAALPPSR Alpha tubulin Spizellomyces punctatus YES F3 — —
NPDDITNEEYAAFYK Hsp82-like protein Spizellomyces punctatus — — YES F2
NPGYFVEWIPNNVK Beta tubulin Spraguea lophii YES F1 YES F1
NLTERGYSFTTTAER Actin Suillus bovinus — — YES F1
TIQFVDWCTTGFK Alpha tubulin Syncephalis depressa YES F1 YES F1
CVPAAVLGSGAANGAR Putative AMP-binding enzyme Taphrina deformans YES F1 YES F1
SSENAPAIVIDNGSGMCK Actin Trachipleistophora hominis YES F3 — —
Table 3. Fungal proteins after column fractionation in P7 fractions.
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resuspended in 300 μl PBS-Ca (P4). This pellet (P4) was treated with 1.5% sodium deoxycholate and the resulting 
suspension was loaded onto 1.5 ml 35% sucrose in PBS-Ca and centrifuged as before. After this centrifugation 
step, this pellet was resuspended in 300 μl PBS-Ca (P5) and treated with 1,000 IU RNAse T1 and 15 IU DNAse 1 at 
37 °C for 5 min. The resulting suspension was layered onto 1.5 ml of 35% sucrose in PBS-Ca and centrifuged and 
resuspended in 300 μl PBS-Ca to obtain pellet P6. Finally, the P6 pellet obtained was treated with 1,000 IU RNAse 
T1 and 15 IU DNAse 1 at 37 °C for 5 min and layered onto 1.5 ml 45% sucrose in PBS-Ca and centrifuged. It was 
then resuspended in 300 μl of PBS-Ca to obtain pellet P7.
Immunohistochemistry. Tissue sections from the CNS (5 μm) were fixed in 10% buffered formalin for 24 h 
and embedded in paraffin following standard protocols. Methods for immunohistochemical analysis have been 
previously described in detail34.
Western blotting. CA proteins were separated by SDS-PAGE (4–12% polyacrylamide), transferred to nitro-
cellulose membranes by wet immunotransfer and processed for western blotting as described38 after blocking the 
membranes with 1% bovine serum albumin. Rabbit polyclonal antibodies against eIF4GI52, Candida albicans and 
Phoma betae34 have been described previously. Mouse monoclonal antibodies against peptidoglycan and human 
α-tubulin were purchased from Sigma and Thermo Scientific, respectively. The goat polyclonal antibody against 
elongation factor eEF2 was purchased from Santa Cruz Biotechnology. Stripping of the nitrocellulose membrane 
was accomplished in some instances to test different antibodies.
Mass Spectrometry Analysis. The methodology for mass spectrometry (MS) analysis has been described 
in detail elsewhere36. Briefly, proteins from INCO samples were separated by PAGE under reducing conditions 
using a 12.5% separating gel and a 5% stacking gel. Protein staining was carried out with GelCode Blue Stain 
Reagent (Thermo Scientific). Proteins were digested in situ with sequencing grade trypsin (Promega, Madison, 
WI). Digestion was stopped by the addition of 1% trifluroacetic acid. The desalted protein digest was dried, 
resuspended in 10 µl of 0.1% formic acid and analyzed by RP-LC-MS/MS in an Easy-nLC II system coupled to 
a LTQ-Orbitrap Velos Pro hybrid mass spectrometer (Thermo Scientific). ESI ionization was performed using a 
stainless steel nano-bore emitter (Proxeon, ID 30 μm). The Orbitrap mass resolution was set at 30,000.
To perform a more in-depth analysis of the peptides obtained after trypsin digestión, whole supernatants were 
dried down, reconstituted in 0.1% TFA and then loaded onto a high-pH, reversed-phase fractionation spin col-
umn (Pierce). A step gradient of increasing acetonitrile concentrations in a volatile high-pH solution was applied 
to elute bound peptides into nine different fractions. After collecting together alternate fractions into three groups 
(F1 = 1 + 4 + 7, F2 = 2 + 5 + 8, F3 = 3 + 6 + 9), samples were dried and stored for MS analysis. To do this, each 
pool of fractions was resuspended in 10 μl of 0.1% formic acid and analyzed as described above.
Processing of the MS data was carried out as previously described36. Database searching was performed 
against uniprot-homo fasta and uniprot-fungi fasta.
Nested PCR assay. DNA was extracted from frozen tissue using the QIAmp Genomic DNA Isolation 
Kit (Qiagen, Hilden, Germany) as previously described33. To amplify the intergenic sequences 1 and 2 (ITS-1 
and ITS-2) from fungal DNA, we performed nested PCR using the oligonucleotide primers and conditions 
described36. In addition, human mitochondrial DNA (mtDNA, D-loop region) was amplifed following the proto-
col described by Ghatak et al.53. RT-PCR analysis of the human 18S rRNA was performed using the primers 18SF 
5′GTAACCCGTTGAACCCCATT 3′and 18SR 5′ CCATCCAATCGGTAGTAGCG 3′.
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